165 related articles for article (PubMed ID: 11173539)
1. Alterations of the transforming growth factor-beta signaling pathway in hepatocellular carcinomas induced endogenously and exogenously in rats.
Sasaki Y; Tsujiuchi T; Murata N; Tsutsumi M; Konishi Y
Jpn J Cancer Res; 2001 Jan; 92(1):16-22. PubMed ID: 11173539
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the M6p/Igf2 receptor gene in hepatocellular carcinomas induced by N-nitrosodiethylamine and a choline-deficient L-amino acid-defined diet in rats.
Tsujiuchi T; Sasaki Y; Oka Y; Kuniyasu H; Konishi Y; Tsutsumi M
Mol Carcinog; 2004 Apr; 39(4):199-205. PubMed ID: 15057872
[TBL] [Abstract][Full Text] [Related]
3. Different mutation patterns of mitochondrial DNA displacement-loop in hepatocellular carcinomas induced by N-nitrosodiethylamine and a choline-deficient l-amino acid-defined diet in rats.
Onishi M; Sokuza Y; Nishikawa T; Mori C; Uwataki K; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2007 Oct; 362(1):183-187. PubMed ID: 17697670
[TBL] [Abstract][Full Text] [Related]
4. Absence of p16, p21 and p53 gene alterations in hepatocellular carcinomas induced by N-nitrosodiethylamine or a choline-deficient L-amino acid-defined diet in rats.
Sasaki Y; Tsujiuchi T; Murata N; Kubozoe T; Tsutsumi M; Konishi Y
Cancer Lett; 2000 Apr; 152(1):71-7. PubMed ID: 10754208
[TBL] [Abstract][Full Text] [Related]
5. Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors.
Obo Y; Yamada T; Furukawa M; Hotta M; Honoki K; Fukushima N; Tsujiuchi T
Mutat Res; 2009 Jan; 660(1-2):47-50. PubMed ID: 19000703
[TBL] [Abstract][Full Text] [Related]
6. Different frequencies and patterns of beta-catenin mutations in hepatocellular carcinomas induced by N-nitrosodiethylamine and a choline-deficient L-amino acid-defined diet in rats.
Tsujiuchi T; Tsutsumi M; Sasaki Y; Takahama M; Konishi Y
Cancer Res; 1999 Aug; 59(16):3904-7. PubMed ID: 10463579
[TBL] [Abstract][Full Text] [Related]
7. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
8. Mutations and aberrant transcriptions of Stk11 (Lkb1) gene in rat liver tumors.
Wakabayashi N; Okabe K; Hayashi M; Honoki K; Tsujiuchi T
Anticancer Res; 2011 Feb; 31(2):543-7. PubMed ID: 21378336
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of transforming growth factor beta type II receptor, Smad2, and Smad4 in hepatocellular carcinoma.
Kawate S; Takenoshita S; Ohwada S; Mogi A; Fukusato T; Makita F; Kuwano H; Morishita Y
Int J Oncol; 1999 Jan; 14(1):127-31. PubMed ID: 9863018
[TBL] [Abstract][Full Text] [Related]
10. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
[TBL] [Abstract][Full Text] [Related]
11. Mutations of the Smad2 and Smad4 genes in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Tsujiuchi T; Sasaki Y; Tsutsumi M; Konishi Y
Mol Carcinog; 2000 Oct; 29(2):87-91. PubMed ID: 11074605
[TBL] [Abstract][Full Text] [Related]
12. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
[TBL] [Abstract][Full Text] [Related]
13. Smad2 and Smad4 gene mutations in hepatocellular carcinoma.
Yakicier MC; Irmak MB; Romano A; Kew M; Ozturk M
Oncogene; 1999 Aug; 18(34):4879-83. PubMed ID: 10490821
[TBL] [Abstract][Full Text] [Related]
14. Distinct DNA methylation patterns of lysophosphatidic acid receptor genes during rat hepatocarcinogenesis induced by a choline-deficient L-amino acid-defined diet.
Okabe K; Hayashi M; Yoshida I; Nishimura K; Fukushima N; Tsujiuchi T
Arch Toxicol; 2011 Oct; 85(10):1303-10. PubMed ID: 21290119
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
[TBL] [Abstract][Full Text] [Related]
16. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
17. Infrequent Ki-ras and an absence of p53 mutations in hepatocellular carcinomas induced by a choline deficient L-amino acid defined diet in rats.
Tsujiuchi T; Kido A; Nakae D; Takahama M; Majima T; Kobitsu K; Okajima E; Tsutsumi M; Denda A; Konishi Y
Cancer Lett; 1996 Nov; 108(1):137-41. PubMed ID: 8950220
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of PAI-1 is mediated through TGF-beta/Smad pathway in transplant arteriopathy.
Dong C; Zhu S; Wang T; Yoon W; Goldschmidt-Clermont PJ
J Heart Lung Transplant; 2002 Sep; 21(9):999-1008. PubMed ID: 12231371
[TBL] [Abstract][Full Text] [Related]
19. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fisher 344 male rats [Mechanisms of Ageing and Development 123 (2002) 1665-1680].
Lim IK
Mech Ageing Dev; 2003 May; 124(5):697-708. PubMed ID: 12825548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
